$FBLG 4 SEC Filings

Filed On	Filing
15 Sep 2026	Form 4: Khoja Hamid, Chief Scientific Officer Received 298,508 shares as a grant or award ($500K) · Granted 298,508 Warrant (Right to Buy)
23 Jun 2026	Form 4: Hoffman Robert E., Director Granted 30,803 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Cilento Richard C. Jr., Director Granted 30,803 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Link Matthew, Director Granted 30,803 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Niklas Victoria Ninon Olivia, Director Granted 30,803 Stock Option (Right to Buy)
04 May 2026	Form 4: Davis Jason, Chief Financial Officer Granted 61,607 Stock Option (Right to Buy)
04 May 2026	Form 4: Garcia Ruben A, General Counsel Granted 61,607 Stock Option (Right to Buy)
04 May 2026	Form 4: O'heeron Pete, Director Granted 92,410 Stock Option (Right to Buy)
04 May 2026	Form 4: Khoja Hamid, Chief Scientific Officer Granted 61,607 Stock Option (Right to Buy)
05 Mar 2026	Form 4: Khoja Hamid, Chief Scientific Officer Bought 30,000 shares ($11.4K)
04 Mar 2026	Form 4: O'heeron Pete, Director Bought 17,428 shares ($6.15K) · Bought 18,200 shares ($7.37K) · Bought 15,872 shares ($6.01K)
03 Mar 2026	Form 4: Davis Jason, Chief Financial Officer Bought 70,000 shares ($29K)
02 Mar 2026	Form 4: Garcia Ruben A, General Counsel Bought 40,000 shares ($13.1K)
12 Dec 2025	Form 4: Garcia Ruben A, General Counsel Bought 140,000 shares ($47.6K)
12 Jun 2025	Form 4: Niklas Victoria Ninon Olivia, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Link Matthew, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Hoffman Robert E., Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Coen Stacy Ann, Director Granted 22,000 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Cilento Richard C. Jr., Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2025	Form 4: Davis Jason, Chief Financial Officer Granted 450,000 Stock Option (Right to Buy)

Comments